Nuvalent, Inc.
Board Member
2025-06-18–present
Nuvalent, Inc.
Board Member
Nuvalent, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Christy J. Oliger is recorded as Board Member at Nuvalent, Inc.. Nuvalent, Inc. reported in an 8-K filed July 15, 2026 that Christy J. Oliger resigned as director, effective July 15, 2026. Nuvalent, Inc. reported in an 8-K filed June 20, 2025 that Christy J. Oliger was appointed member of the Audit Committee of the Board, effective June 18, 2025. Nuvalent, Inc. reported in an 8-K filed June 20, 2025 that Christy J. Oliger was appointed member of the Board, effective June 18, 2025.
“In accordance with the Merger Agreement, at the Effective Time, each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company's board of directors, and any committee thereof.”
“Also, in accordance with the recommendation of the NCG Committee, the Board appointed Ms. Oliger as a member of the Audit Committee of the Board (the "Audit Committee"), effective immediately following her election to the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Nuvalent, Inc.
SEC 8-K
2025-06-18–present
Nuvalent, Inc.
Board Member
SEC 8-K
2025-06-18–present
Nuvalent, Inc.
Board Member
SEC 8-K
2025-06-18–2026-07-15
Recorded roles and call appearances connecting this person to public companies.
Nuvalent, Inc.
Board Member
2025-06-18–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.